Sensyne Health plc
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Sensyne Health plc
Finance Watch: 3T Biosciences Emerges With $40m And Novel TCR Platform
Private Company Edition: Westlake Village BioPartners’ latest launch 3T Biosciences also licensed a second TCR platform from Stanford University. In other recent financings, Senda raised a $123m series C round, Orna revealed a $221m series B and CPRIT funded several cancer drug developers.
Not All AI Companies Are A Success: The Woes Of Sensyne
The business founded by Lord Drayson has struggled to achieve commercial success for its artificial intelligence products.
Spanish Team’s AI Model For Pandemic Response Named XPRIZE Winner
VALENCIA IA4COVID19’s AI model won the XPRIZE Pandemic Response Challenge grand prize. Researchers are pinning their hopes on AI to help predict the next pandemic, but also for early diagnosis of COVID-19.
Digital Health Roundup, January/February 2021: The Continued Rise Of AI, Telehealth
In this new roundup feature focusing on the most notable developments in digital health, we pick the key news from the year so far.
- Monitoring Equipment & Devices
- Artificial Intelligence
Drug Discovery Tools
- Drug Discovery Tools
- Other Names / Subsidiaries
- Drayson Health Ltd
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.